SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000932440-16-000318
Filing Date
2016-02-12
Accepted
2016-02-12 16:05:23
Documents
1
Group Members
ALAIN SCHREIBERJAY MOORINPROQUEST ASSOCIATES IV LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sch13-a_4252575.htm SC 13G/A 125705
  Complete submission text file 0000932440-16-000318.txt   127334
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Subject) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85368 | Film No.: 161418891
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109
Business Address 2430 VANDERBILT BEACH ROAD #108 - 190 NAPLES FL 34109 609-919-3567
ProQuest Investments IV, L.P. (Filed by) CIK: 0001431818 (see all company filings)

IRS No.: 205935001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A